Skip Navigation
Search Menu
Find a Doctor


Photo of Dr. Saleh Alqahtani

Saleh Alqahtani, M.B.B.S.

Director of Clinical Liver Research
Assistant Professor of Medicine

Male  | Languages: English, Arabic

Appointment Phone


Main Location

The Johns Hopkins Hospital

Out-of-State & International Patients +
Out of State Patients

Call 410-464-6641 (8a.m. to 6p.m., EST, Mon-Fri)

Learn more about our out-of-state patient services »

International Patients

Call +1-410-502-7683 (7a.m. to 6p.m., EST, Mon-Fri)

Learn more about our international patient services »


  • Director of Clinical Liver Research
  • Assistant Professor of Medicine

Centers & Institutes



The Johns Hopkins Hospital

Appointment Phone: 410-933-7495

600 N. Wolfe Street
Sheikh Zayed Tower
Baltimore, MD 21287 map
Phone: 410-955-3779

Johns Hopkins Outpatient Center

Appointment Phone: 410-933-7495

601 N. Caroline Street
Baltimore, MD 21287 map
Phone: 410-933-7495

Contact for Research Inquiries

720 Rutland Avenue
Ross Building, Suite 918
Baltimore, MD 21205 map


Cirrhosis, Colon Polyps, Colonoscopy, Digestive Diseases, Endoscopy, Fatty Liver, Gastroenterology, Gastroesophageal Reflux Disease (GERD), Gastrointestinal Bleeding, Hepatitis, Hepatitis B virus infection (HBV), Hepatitis C Virus infection (HCV), Indigestion, Liver Biopsies, Liver Cancer, Liver Fibrosis, Liver Transplant , Liver Transplant Evaluation, Pancreatic and Biliary Disease

Research Interests

Drug Induced Liver Injury; Liver Cancer; Hepatitis B; Hepatitis C; Fatty Liver Disease


Saleh Alqahtani is the director of clinical liver research at The Johns Hopkins Hospital. He is an expert in liver and digestive diseases, endoscopy, and liver transplant. Dr. Alqahtani previously was the associate director of the Gastroenterology fellowship program at the University of Texas Southwestern Medical Center in Dallas. He also served as an instructor in Medicine at Mayo Clinic, and faculty at Um Alqura University.

He earned his medical degree at King Abdulaziz University in Saudi Arabia, completed an internal medicine residency at University of Western, performed a gastroenterology fellowship at the University of Calgary and completed an advanced hepatology fellowship at Mayo Clinic.

Dr. Alqahtani has been an invited speaker both nationally and internationally, having lectured in Latin America, Asia and Europe. He has been recognized with several awards and honors, authored numerous publications and book chapters, and is board certified in transplant hepatology, gastroenterology and internal medicine. more

Featured Video

Fatty Liver Disease - Q&A

More Videos

    Additional Information

  • Education +


    • King Abdul Aziz University / MBChB (1999)


    • University of Western Ontario / Internal Medicine (2004)


    • University of Calgary / Gastroenterology (2007)
    • Mayo Medical School College of Medicine (2008)


    • American Board of Internal Medicine / Gastroenterology (2007)
    • American Board of Internal Medicine / Transplant Hepatology (2010)
  • Research & Publications +

    Clinical Trials:

    Fatty Liver, Hepatitis C, Hepatitis B, Liver cancer, Liver transplant, Liver failure, Cirrhosis

    Clinical Trial Keywords: Hepatitis C, Fatty Liver, Liver Cancer, Liver Transplant

    Selected Publications

    Alqahtani SA, Coffin CS, Burak KW, Chen F, MacGregor J, Beck P. Hepatic portal venous gas: a report of two cases and a review of the epidemiology, pathogenesis, diagnosis and approach to management. Canadian J of Gastroenterology. 2007 May; 21(5):309-13.

    Alqahtani SA, Federico P, Myers RP. A case of valproate-induced hyperammonemic encephalopathy: look beyond the liver. Canadian Medical Association Journal. 2007 Sep 11; 177(6):568-9.

    Asfaha S, Alqahtani SA, Maclean T, Hilsden B, Beck PB. Assessment of Endoscopic Training of General Surgery Residents in a North American Health Region. Gastrointestinal Endoscopy. 2008 Dec; 68(6): 1056-62.

    Federico P, Alqahtani SA, Myers RP. Possible new clinical sign of hyperammonemia. Canadian Medical Association Journal. 2008 Jan 29; 178 (3).

    Alqahtani SA. Hepatitis C, What Clinicians need to know? Canadian Journal of Diagnosis. 2008 Jan 1. P: 72-76

    Alqahtani SA, Lee SS, Cirrhotic Cardiomyopathy, Seminars in Liver Disease Journal. 2008, Feb, 28(1): 59-69

    Alqahtani SA, Sanchez W. Statins Are Safe for the Treatment of Hypercholestrolemia in Patients with Chronic Liver Disease. Gastroenterology Journal. 2008 July 8

    Alhamoudi WK, Alqahtani SA, Ma M, Lee SS. Hemodynamic in the Immediate Postoperative Period after Liver Transplantation in Alcoholic and Post-viral Cirrhosis. World J Gastroenterol. 2010 Feb 7; 16(5): 608-12.

    Alhamoudi W, Mohamed H, Abaalkhail F, Kamel Y, Almasiro N, Allam N, Alqahtani SA, Alosofyan M, Khalaff H, Alsebeyel M, Aljedai A, Abdo A. Treatment of Genotype-4 Hepatitis C Recurring After Liver Transplantation Using a Combination of Pegylated Interferon Alfa-2a and Ribavirin. Digestive Diseases and Sciences Journal, 2011 Jan 8.

    Alqahtani SA, Larson AM. Adult Liver transplantation in the USA. Curr Opin Gastroenterology. 2011 May; 27(3): 240-7

    Alqahtani SA. Update in Liver transplantation. Current opinion in Gastroenterology, Curr Opin Gastroenterol. 2012 May; 28 (3): 230-8.

    Alqahtani SA. Update in Liver transplantation. Discov Med. 2012 Aug; 14(75):133-41.

    Al-Hamoudi W, Ali S, Hegab B, Elsiesy H, Hashim A, Al-Sofayan M, Khalaf H, Al-Bahili H, Al-Masri N, Al-Sebayel M, Broering D, Abdo A, Alqahtani SA, Abaalkhail F. Revising the upper limit of normal for levels of serum alanine aminotransferase in a middle eastern population with normal liver histology. Dig Dis Sci. 2013 Aug; 58(8):2369-75

    Singal AG, Dharia TD, Malet PF, Alqahtani SA, Zhang S, Cuthbert JA. Long-term benefit of hepatitis C therapy in a safety net hospital system: a cross-sectional study with median 5-year follow-up. BMJ Open, 2013 Sep 3;3(9)

    Woreta T, Alqahtani SA, Evaluation of Abnormal Liver Tests. Medical Clinics of North America Journal. 2014 Jan;98(1):1-16

    Alqahtani SA, Kleiner DE, Ghabril M, Gu J, Hoofnagle JH, Rockey DC; DILIN study investigators Identification and Characterization of Cefazolin-induced Liver Injury. Clin Gastroenterol Hepatol. 2015 Jul;13(7):1328-1336.e2. doi: 10.1016/j.cgh.2014.11.036.

    Alqahtani SA, Afdhal N, Zeuzem S, Gordon S, Mangia A, Kwo P, Fried M, Yang JC, Ding X, Pang PS, McHutchison JG, Pound D, Reddy KR, Marcellin P, Kowdley KV, Sulkowski M. Safety and Tolerability of Ledipasvir/Sofosbuvir with and without Ribavirin in Patients with Chronic HCV Genotype 1 Infection: Analysis of Phase 3 ION trials. Hepatology. 2015 Jul;62(1):25-30. doi: 10.1002/hep.27890

    Dhingra A, Kapoor S, Alqahtani SA, Recent advances in the treatment of hepatitis C.Discov Med. 2014 Oct;18(99):203-8.

    Alqahtani SA, Watt K. Liver transplantation: Indications and patient selection. In Practical Gastroenterology and Hepatology. ISBN 978-1405182751. Wiley-Blackwell. 2010

    Alqahtani SA, Larson AM, Liver transplantation for acute liver failure. In Liver transplantation. ISBN 978-953-51-0016-4, InTech, February 2012

    Alqahtani SA. Sulkowski MS. Current and Evolving Treatments for Genotype 1 Hepatitis C Virus. Gastroenterology Clinics of North America (in press)

  • Academic Affiliations & Courses +
  • Activities & Honors +
  • Videos & Media +


    Hepatitis C - What You Need To Know

    Saleh Alqahtani, MD, Assistant Professor of Medicine, Johns Hopkins Gastroenterology & Hepatology, discusses what you need to know about Hepatitis C. For more information:

    Recent News Articles & Media Coverage

    New Therapy for Hepatitis C, Inside Tract, July 5, 2013

Is This You? Edit Profile